Laurus Labs Double top buy active - 1%*3 Box size and reversal.

Syngene - a long route opened. 1%*3 PnF

Asian Paints - you need to be flexible for the chart reading. Do not try to impose a pattern when there is none. Sometimes, a simple trend line would serve the purpose.

Here, please understand the concept of the "Internal Trend Line" and its significance.

Power grid and an upward sloping channel working in here.

Divis Labs - even though the business may be great but the price may remain subdued for a longer time. It must spend considerable time here to consolidate itself.

#LAURUSLABS - CONCALL SNIPPET !

SHALL I CALL IT "EVERYONE'S FAVORITE" IN PHARMA SPACE!

(Only For Educational Purpose)

Laurus Labs Deep Analysis

Originally Published: @FinnickClub

Covers:
🧫 Management Analysis
🧫 API & Formulation Business
🧫 Custom Synthesis & Ingredients
🧫 Financial Performance Overview
🧫 Company Analysis by @soicfinance

@Investor_Mohit

Laurus Labs FY21 Annual Report Takeaways 🔬

'Capex plans are already under way to increase capacity by 1.8x by 2022'

Hit the 'retweet' & help us educate more investors.

A Thread 🧵👇

1/ About the company:

Leadership position in generic APIs with a major focus on Antiretroviral drugs, Hepatitis C & Oncology drugs

FDF: Moved up the value chain in formulations

Synthesis (CDMO): KSMs, Intermediates & APIs to pharma innovators.

Bio: Recombinant products

2/ Strengths of the business:

Robust R&D & Process chemistry skills
Compliance that meets the most stringent regulatory expectations (USFDA, etc)
Long-standing relationships | Top 10 global pharma cos. catered

750+ scientists (R&D) | 61 DMFs | 27 ANDAs | 150 patents (292 filed)

3/ APIs: 54% of rev

- Leaders in various high-value & high-volume APIs.
- 4 high potent manufacturing facilities: 4186 KL, increasing capacity by 24% (Strong demand)
- ARV APIs were up 70% | Onco APIs up 25% | Other APIs up 56% (higher contract manufacturing orders from 🇪🇺)

4/ Formulations: 35% of rev

- Backwardly integrated: in house APIs
- Sales to LMIC, 🇺🇸 & 🇪🇺
- 27 ANDA filled: 9 approved+ 8 tentative.
- Capacity of 5 Billion units/yr, Increasing capacity by 100%
- Sales up 102% (growth across markets)
- Launched TLE 400 in the LMIC market

#LAURUSLAB-651

Now above 6.857%(520) further extension shown in chart.

Base Case 520.

#Probability